StemPro™ MSC SFM XenoFree
StemPro™ MSC SFM XenoFree
인용 및 참조 문헌 (13)
Gibco™

StemPro™ MSC SFM XenoFree

GIBCO® StemPro® MSC SFM XenoFree는 완전한 serum free 및 무이종발생(xeno-free) 조건에서 인간 간엽성 줄기세포(MSC), 지방 유래 줄기세포(ADSC)의 성장과 확장을 위해자세히 알아보기
Have Questions?
카탈로그 번호수량
A10675011 Kit
카탈로그 번호 A1067501
제품 가격(KRW)
699,000
온라인 행사
Ends: 31-Dec-2025
776,000
할인액 77,000 (10%)
Each
카트에 추가하기
수량:
1 Kit
제품 가격(KRW)
699,000
온라인 행사
Ends: 31-Dec-2025
776,000
할인액 77,000 (10%)
Each
카트에 추가하기
GIBCO® StemPro® MSC SFM XenoFree는 완전한 serum free 및 무이종발생(xeno-free) 조건에서 인간 간엽성 줄기세포(MSC), 지방 유래 줄기세포(ADSC)의 성장과 확장을 위해 개발되었습니다. StemPro® MSC SFM XenoFree를 사용하여 인간 MSC 또는 ADSC를 여러 번 계대배양으로 확장하며 이들의 multipotency(즉, 골수, 연골, 지방 분화력)을 유지할 수 있습니다. StemPro® MSC SFM XenoFree는 cGMP에 따라 추적가능성(traceability)과 제조의 신뢰성이 보장됩니다.
For Research Use Only. Not for use in diagnostic procedures.
사양
세포 유형Mesenchymal Stem Cells
배양 환경CO2
항생제 포함No antibiotics
제품라인StemPro
제품 유형Stem Cell Serum Free Media (SFM)
순도 또는 품질 등급MS Cell-Qualified
수량1 Kit
종Human
분류Xeno-free
Culture TypeAdherent Cell Culture
형태Liquid
Serum LevelSerum-free
첨가제 없음No Glutamine, No Phenol Red
Unit SizeEach
구성 및 보관
Each kit contains 1 x 500 ml StemPro™ MSC SFM Basal Medium and 1 X 5 ml StemPro™ MSC SFM XenoFree Supplement. StemPro™ MSC SFM Basal Medium is stored at 2 to 8°C and stable for 12 months. The StemPro™ MSC SFM XenoFree Supplement is stored frozen at -5 to -20°C and stable for 12 months.

자주 묻는 질문(FAQ)

What is the concentration of sodium bicarbonate in StemPro MSC SFM XenoFree?

StemPro MSC SFM XenoFree contains 2.2 g/L of sodium bicarbonate.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

인용 및 참조 문헌 (13)

인용 및 참조 문헌
Abstract
Exosomes Produced from 3D Cultures of MSCs by Tangential Flow Filtration Show Higher Yield and Improved Activity.
Authors:Haraszti RA,Miller R,Stoppato M,Sere YY,Coles A,Didiot MC,Wollacott R,Sapp E,Dubuke ML,Li X,Shaffer SA,DiFiglia M,Wang Y,Aronin N,Khvorova A
Journal:Molecular therapy : the journal of the American Society of Gene Therapy
PubMed ID:30341012
Exosomes can deliver therapeutic RNAs to neurons. The composition and the safety profile of exosomes depend on the type of the exosome-producing cell. Mesenchymal stem cells are considered to be an attractive cell type for therapeutic exosome production. However, scalable methods to isolate and manufacture exosomes from mesenchymal stem cells ... More
Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles.
Authors:Bobis-Wozowicz S,Kmiotek K,Kania K,Karnas E,Labedz-Maslowska A,Sekula M,Kedracka-Krok S,Kolcz J,Boruczkowski D,Madeja Z,Zuba-Surma EK
Journal:Journal of molecular medicine (Berlin, Germany)
PubMed ID:27638341
ABSTRACT: Growing evidence indicates that intracellular signaling mediated by extracellular vesicles (EVs) released by stem cells plays a considerable role in triggering the regenerative program upon transplantation. EVs from umbilical cord mesenchymal stem cells (UC-MSC-EVs) have been shown to enhance tissue repair in animal models. However, translating such results into ... More
Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions.
Authors:Santos Fd,Andrade PZ,Abecasis MM,Gimble JM,Chase LG,Campbell AM,Boucher S,Vemuri MC,Silva CL,Cabral JM
Journal:Tissue engineering. Part C, Methods
PubMed ID:21895491
The immunomodulatory properties of mesenchymal stem cells (MSCs) make them attractive therapeutic agents for a wide range of diseases. However, the highly demanding cell doses used in MSC clinical trials (up to millions of cells/kg patient) currently require labor intensive methods and incur high reagent costs. Moreover, the use of ... More
A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue.
Authors:Carmelo JG, Fernandes-Platzgummer AM, Diogo MM, Lobato da Silva C, Cabral JM,
Journal:
PubMed ID:26136376
'Human mesenchymal stem/stromal cells (MSC) are promising candidates for cell-based therapies and the development of microcarrier-based cultures in scalable bioreactors with well-defined xenogeneic-free components represent important milestones towards the clinical-scale production of these cells. In this work, we optimized our previously developed xeno-free microcarrier-based system for the scalable expansion of ... More
Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media.
Authors:Oikonomopoulos A, van Deen WK, Manansala AR, Lacey PN, Tomakili TA, Ziman A, Hommes DW,
Journal:
PubMed ID:26564250
'Due to their immunosuppressive properties, mesenchymal stem cells (MSC) have been evaluated for the treatment of immunological diseases. However, the animal-derived growth supplements utilized for MSC manufacturing may lead to clinical complications. Characterization of alternative media formulations is imperative for MSC therapeutic application. Human BMMSC and AdMSC were expanded in ... More
View all StemPro™ MSC SFM XenoFree citations